PGR and breast cancer: They found one third of a cohort of ER positive breast cancers had a functionally inactive ER pathway score which was associated significantly with non-responding hormone status.69 Studies such as this would be extremely valuable in EC and may explain why response rates to hormonal agents in ER/PR positive EC have been disappointingly low.